magqu 产品代理

Analyzer

IMR Reagent

Beads and Separator

Since the start-up in 2008, MagQu has utilized her core technology, so-called ImmunoMagnetic Reduction (IMR), to develop dozens of products, such as in-vitro diagnostic (IVD) assay kits and analyzers for colorectal cancer, Alzheimer’s disease, Down’s syndrome, preterm birth, inflammatory disease, grouper viruses etc. The R&D and manufacture of products have been certified with both ISO including 9001 and 13485, and GMP. In addition, the immunoassay analyzers have been approved as Class-I Medical Device by Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare. Some of assay kits will be certificated with CE-IVD (2015) and TFDA (2016). We successfully made them on the shelf for life-science markets in China, Japan, Korea, Malaysia, Turkey, USA, UK, and Germany. Up to now, the authorized capital has been raised from 3 million to 1.5 hundred million TWD since 2008. With the bright achievements and impressive progresses, MagQu has been frequently awarded by Ministry of Economics, Council of Agriculture, and associations in Taiwan. MagQu is expected for colorectal cancer (Class II), Alzheimer’s disease (Class III) product marketing authorization of Health, Welfare Ministry in 2016. We also plan to start clinical trials of USA and Europe and place to set up branches, expanding in vitro diagnostic reagent market. During that time, MagQu has developed a grouper virus detection kit, and has been sold in the market. MagQu has initiated internal control/audit system, planning public offering of stock in 2016.